Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 76

1.

[What's new in HIV/AIDS: Some selected topics].

Vu DL, Daou S, Ambrosioni J, Calmy A.

Rev Med Suisse. 2013 Jan 16;9(369):150-5. French.

PMID:
23409658
2.

[HIV and AIDS: what's new in 2010?].

Calmy A, Schiffer V, Hirschel B.

Rev Med Suisse. 2011 Jan 19;7(278):159-63. French.

PMID:
21400951
3.

Current use of antiretroviral treatment.

Bailey AC, Fisher M.

Br Med Bull. 2008;87:175-92. doi: 10.1093/bmb/ldn032. Epub 2008 Aug 29. Review.

PMID:
18757468
4.

Antiretrovirals for HIV prevention: when should they be recommended?

Kiselinova M, De Spiegelaere W, Verhofstede C, Callens SF, Vandekerckhove L.

Expert Rev Anti Infect Ther. 2014 Apr;12(4):431-45. doi: 10.1586/14787210.2014.896739. Review.

PMID:
24621251
5.

[Revised guideline "Antiretroviral Treatment"].

Werkgroep antiretrovirale behandeling van de Nederlandse Vereniging van Aids Behandelaren.

Ned Tijdschr Geneeskd. 2005 Oct 22;149(43):2399-405. Review. Dutch.

PMID:
16277129
7.

[Interference among antiretroviral, anti-HCV, and immunosuppressive treatments].

Peytavin G.

Med Mal Infect. 2004 Nov;34 Spec No 2:20-1. French. No abstract available.

PMID:
15801535
8.

[The post-exposure prophylaxis in all its forms].

Wassilew N, El Amari EB, Bonfillon C, Yerly S, Calmy A.

Rev Med Suisse. 2013 Apr 24;9(383):872, 874-8. French.

PMID:
23697081
9.

The effect of antiretroviral therapy on liver disease among adults with HIV and hepatitis C coinfection.

Mehta SH, Thomas DL, Torbenson M, Brinkley S, Mirel L, Chaisson RE, Moore RD, Sulkowski MS.

Hepatology. 2005 Jan;41(1):123-31.

PMID:
15619237
10.

Postexposure prophylaxis for HIV: pivotal intervention for those at risk.

Sharifi-Azad J, Rizzolo D.

JAAPA. 2011 Aug;24(8):22-5. No abstract available.

PMID:
21850915
11.

[HCV / HIV co-infection: a different perspective].

Jmelnitzky AC.

Acta Gastroenterol Latinoam. 2002 May;32(1):7-10. Review. Spanish.

PMID:
12136694
12.

Prevention of mother-to-child transmission of HIV: antiretroviral strategies.

Read JS.

Clin Perinatol. 2010 Dec;37(4):765-76, viii. doi: 10.1016/j.clp.2010.08.007. Review.

PMID:
21078449
13.

[Co-infection with HIV and viral hepatitis C].

Pialoux G.

Med Mal Infect. 2006 Jul;36 Suppl 2:S218-23. French. No abstract available.

PMID:
17076000
14.

Study of the impact of HIV genotypic drug resistance testing on therapy efficacy.

Van Vaerenbergh K.

Verh K Acad Geneeskd Belg. 2001;63(5):447-73. Review.

PMID:
11813503
15.

HIV and hepatitis C coinfection within the CAESAR study.

Amin J, Kaye M, Skidmore S, Pillay D, Cooper DA, Dore GJ.

HIV Med. 2004 May;5(3):174-9.

16.

[Guideline 'Needlestick injuries': risk assessment and post-exposure management in practice].

Ruijs WL, Timen A.

Ned Tijdschr Geneeskd. 2008 Sep 6;152(36):1967-71. Review. Dutch.

PMID:
18807333
17.

Schizophrenia and comorbid human immunodeficiency virus or hepatitis C virus.

Cournos F, McKinnon K, Sullivan G.

J Clin Psychiatry. 2005;66 Suppl 6:27-33. Review.

PMID:
16107181
18.

Postexposure prophylaxis for HIV following sexual exposure.

Barber TJ, Benn PD.

Curr Opin HIV AIDS. 2010 Jul;5(4):322-6. doi: 10.1097/COH.0b013e32833a5e6c. Review.

PMID:
20543608
19.

Update of the past year: a review from IDSA 2011.

McCollum DL.

Top Antivir Med. 2011 Dec;19(5):187-92. Review.

20.

Advances in antiretroviral therapy.

Wilkin TJ, Shalev N, Tieu HV, Hammer SM.

Top HIV Med. 2010 Apr-May;18(2):66-92. Review.

Supplemental Content

Support Center